Marrone bio innovations inc. announces positive results for the 2019 field trials for its novel bioherbicide, known as mbi-015

Marrone bio innovations inc. announced positive results for the 2019 field trials for its novel bioherbicide, known as mbi-015. field tests conducted in 2019 using commercial rates for marrone bio's novel bioherbicide demonstrated control of a target weed approaching that of a current post-emergent chemical herbicide. at commercial rates across multiple trial locations that used uniform protocols, control of palmer amaranth was evaluated at three stages of growth, 7-to-10 days after mbi-015 was applied. control ranged from the mid-70% to the high-80% ranges. palmer amaranth is a noxious weed that has spread rapidly, and has developed resistance to eight herbicidal modes of action.1Â left unchecked, this weed can lead to dramatic yield losses in crops such as corn and soybeans. the company also has been issued u.s. patent 8,822,193, which covers claims related to pre- and post-emergent herbicidal activity to control weeds for its bioherbicide. additional regulatory and patent submissions are planned for both mbi-015, a liquid formulation for use in conventional crops, and mbi-014, a granular formulation of the bioherbicide targeted for organic use. the company also holds patents related to the underlying bacteria used in the bioherbicide and its associated pesticidal compounds.
MBII Ratings Summary
MBII Quant Ranking